Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Kasuga

Showing results (41-50 of 237) with videos related to

Pageof 24
Sort By:
Journal of Diabetes and Its Complications|March 5, 2003
Leptin treatment ameliorates anxiety in ob/ob obese miceAkihiro Asakawa, Akio Inui, Toshio Inui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2004
High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastasesHirotaka Kato, Shuho Semba, Upik A Miskad, et al.
Diabetes Research and Clinical Practice|January 13, 2009
Two related cases of type A insulin resistance with compound heterozygous mutations of the insulin receptor geneWataru Ogawa, Kazuya Iwamoto, Hiroyuki Mori, et al.
Nature Communications|January 4, 2018
Sirt2 facilitates hepatic glucose uptake by deacetylating glucokinase regulatory proteinHitoshi Watanabe, Yuka Inaba, Kumi Kimura, et al.
Journal of Diabetes Investigation|December 10, 2016
New glycemic targets for patients with diabetes from the Japan Diabetes SocietyEiichi Araki, Masakazu Haneda, Masato Kasuga, et al.
Biological & Pharmaceutical Bulletin|July 23, 2002
Optimal dose of omeprazole for CYP2C19 extensive metabolizers in anti-Helicobacter pylori therapy: pharmacokinetic considerationsTomoko Kita, Toshiyuki Sakaeda, Nobuo Aoyama, et al.
Diabetes|May 29, 2002
Role of the insulin receptor substrate 1 and phosphatidylinositol 3-kinase signaling pathway in insulin-induced expression of sterol regulatory element binding protein 1c and glucokinase genes in rat hepatocytesMichihiro Matsumoto, Wataru Ogawa, Kiyoshi Teshigawara, et al.
International Journal of Molecular Medicine|May 11, 2006
Expression of thioredoxin and thioredoxin-binding protein-2 in the liver of patients with chronic hepatitis C as a predictor of response to interferon therapyKenichi Hamano, Yasushi Seo, Hirotaka Kato, et al.
Diabetology International|January 4, 2019
New glycemic targets for patients with diabetes from the Japan Diabetes SocietyEiichi Araki, Masakazu Haneda, Masato Kasuga, et al.
Biochemical and Biophysical Research Communications|December 17, 2009
The t-SNAREs syntaxin4 and SNAP23 but not v-SNARE VAMP2 are indispensable to tether GLUT4 vesicles at the plasma membrane in adipocyteTakayuki Kawaguchi, Yoshikazu Tamori, Hajime Kanda, et al.
Pageof 24

Showing results (41-50 of 237) with videos related to

Sort By:
Pageof 24
Journal of Diabetes and Its Complications|March 5, 2003
Leptin treatment ameliorates anxiety in ob/ob obese miceAkihiro Asakawa, Akio Inui, Toshio Inui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2004
High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastasesHirotaka Kato, Shuho Semba, Upik A Miskad, et al.
Diabetes Research and Clinical Practice|January 13, 2009
Two related cases of type A insulin resistance with compound heterozygous mutations of the insulin receptor geneWataru Ogawa, Kazuya Iwamoto, Hiroyuki Mori, et al.
Nature Communications|January 4, 2018
Sirt2 facilitates hepatic glucose uptake by deacetylating glucokinase regulatory proteinHitoshi Watanabe, Yuka Inaba, Kumi Kimura, et al.
Journal of Diabetes Investigation|December 10, 2016
New glycemic targets for patients with diabetes from the Japan Diabetes SocietyEiichi Araki, Masakazu Haneda, Masato Kasuga, et al.
Biological & Pharmaceutical Bulletin|July 23, 2002
Optimal dose of omeprazole for CYP2C19 extensive metabolizers in anti-Helicobacter pylori therapy: pharmacokinetic considerationsTomoko Kita, Toshiyuki Sakaeda, Nobuo Aoyama, et al.
Diabetes|May 29, 2002
Role of the insulin receptor substrate 1 and phosphatidylinositol 3-kinase signaling pathway in insulin-induced expression of sterol regulatory element binding protein 1c and glucokinase genes in rat hepatocytesMichihiro Matsumoto, Wataru Ogawa, Kiyoshi Teshigawara, et al.
International Journal of Molecular Medicine|May 11, 2006
Expression of thioredoxin and thioredoxin-binding protein-2 in the liver of patients with chronic hepatitis C as a predictor of response to interferon therapyKenichi Hamano, Yasushi Seo, Hirotaka Kato, et al.
Diabetology International|January 4, 2019
New glycemic targets for patients with diabetes from the Japan Diabetes SocietyEiichi Araki, Masakazu Haneda, Masato Kasuga, et al.
Biochemical and Biophysical Research Communications|December 17, 2009
The t-SNAREs syntaxin4 and SNAP23 but not v-SNARE VAMP2 are indispensable to tether GLUT4 vesicles at the plasma membrane in adipocyteTakayuki Kawaguchi, Yoshikazu Tamori, Hajime Kanda, et al.
Pageof 24